SCHEMBL7723316

SCHEMBL7723316

C[SiH](C)[SiH](c1ccccc1)c1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.35
LMNA P02545 2/20 0.35
ACHE P22303 2/20 0.35
ALOX12 P18054 1/20 0.35
ALDH1A1 P00352 2/20 0.32
CA4 P22748 2/20 0.30
DAO P14920 1/20 0.30
NAPRT Q6XQN6 1/20 0.30
TP53 P04637 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
CA12 O43570 1/20 0.30
GMNN O75496 1/20 0.30
EGFR P00533 1/20 0.30
CA2 P00918 1/20 0.30
FYN P06241 1/20 0.30
POLB P06746 1/20 0.30
CA3 P07451 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3482296 0.79 ALDH1A1 (0.40) TSHRLMNAACHEALOX12ALDH1A1
SCHEMBL7750789 0.75 TSHR (0.35) TSHRLMNAACHEALOX12ALDH1A1
SCHEMBL1539360 0.73 TSHR (0.39) TSHRLMNAACHEALOX12ALDH1A1
SCHEMBL55166 0.73
SCHEMBL124751 0.73 TSHR (0.39) TSHRLMNAACHEALOX12ALDH1A1
SCHEMBL8382290 0.73 ACHE (0.47) TSHRLMNAACHEALOX12ALDH1A1
SCHEMBL4226112 0.73 TDP1 (0.32) LMNATDP1
SCHEMBL2522935 0.71 TSHR (0.37) TSHRLMNAACHEALOX12ALDH1A1
SCHEMBL2799322 0.71 TSHR (0.37) TSHRLMNAACHEALOX12ALDH1A1
SCHEMBL14875991 0.71 TSHR (0.37) TSHRLMNAACHEALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020147286-A1 Process for producing substantially amorphous propylene-based polymers EQUISTAR CHEMICALS, LP 2002-10-10 US claimed
EP-0630933-B1 A method of producing a semiconducting material NIPPON OIL CO LTD (JP) 1999-04-14 EP disclosed
US-5700400-A Method for producing a semiconducting material NIPPON OIL CO., LTD. (JP) 1997-12-23 US disclosed
EP-0551771-B1 Process for producing polysilanes NIPPON OIL CO LTD (JP) 1997-07-30 EP disclosed
US-5620531-A Photovoltaic element NIPPON OIL CO., LTD. (JP) 1997-04-15 US disclosed
EP-0717451-A2 Photovoltaic element NIPPON OIL CO., LTD. (JP) 1996-06-19 EP disclosed
EP-0630933-A2 A method of producing a semiconducting material NIPPON OIL CO. LTD. (JP) 1994-12-28 EP disclosed
US-5304622-A Process for producing polysilanes NIPPON OIL COMPANY, LTD. (JP) 1994-04-19 US disclosed
EP-0551771-A2 Process for producing polysilanes NIPPON OIL CO. LTD. (JP) 1993-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147286-A1 Process for producing substantially amorphous propylene-based polymers GRB7, CHRM1, CPNE4 TSHR 1288/4885LMNA 3780/4885ACHE 4057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.